Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Oct 14 · above the Ichimoku cloud · RSI 63 · MACD above its signal · 3% below its 52-week high
| 484.47 | R3 (classic) | +3.61% |
| 481.50 | Previous week high | +2.97% |
| 481.50 | 52-week high | +2.97% |
| 481.33 | R2 (classic) | +2.94% |
| 478.20 | Previous day high | +2.27% |
| 475.07 | R1 (classic) | +1.60% |
| 471.93 | Pivot | +0.93% |
| 468.80 | Previous day low | +0.26% |
| 467.60 | Price now | |
| 465.67 | S1 (classic) | −0.41% |
| 465.00 | Previous month high | −0.56% |
| 462.53 | S2 (classic) | −1.08% |
| 456.27 | S3 (classic) | −2.42% |
| 453.40 | Previous week low | −3.04% |
| 414.50 | Previous month low | −11.36% |
| 336.80 | 52-week low | −27.97% |
None of the 29 investors followed here reported a position in NSIS-B.CO in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a NSIS-B.CO trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for NSIS-B.CO.
TimeframesThe daily, weekly and monthly trends are up; the hourly is pausing, a pullback inside them.
pulling back under the 21 EMA
over a rising 21 EMA, 21 over 50
over a rising 21 EMA, 21 over 50
over a rising 21 EMA, 21 over 50
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.4 | -2.6 | 1.9 | 2.2 | -4.7 | 10.8 | 2.2 | 9.6 | -9.3 | 11.5 | +14.7% | ||
| 2025 | 1.3 | 5.1 | -7.7 | 6.3 | 8.4 | -1.7 | -6.2 | -4.7 | -4.1 | -0.5 | 3.7 | 1.5 | +0.0% |
| 2024 | -4.5 | 9.7 | 4.2 | -4.1 | 5.1 | 4.3 | 3.0 | 6.6 | 3.0 | -10.9 | -3.7 | -1.5 | +9.9% |
| 2023 | 0.9 | -4.4 | 3.4 | 0.1 | -4.5 | -5.3 | 7.0 | -12.2 | -4.6 | 11.2 | 12.2 | 4.5 | +5.5% |
| 2022 | -15.7 | -3.9 | 6.4 | 6.7 | -11.0 | -3.2 | 9.0 | -8.3 | -10.0 | 3.3 | 3.7 | -14.3 | −34.5% |
| 2021 | 5.6 | 3.1 | 6.7 | 8.4 | 0.8 | 6.5 | 4.2 | 3.3 | -13.5 | 7.5 | 5.1 | 8.1 | +53.7% |
| 2020 | 7.9 | -2.5 | -9.9 | 7.9 | 9.8 | 4.7 | -1.6 | -2.2 | 8.3 | -4.0 | -7.1 | -2.1 | +7.2% |
| 2019 | -6.5 | 9.4 | 2.8 | 1.4 | 1.4 | -2.7 | 2.4 | -7.7 | -0.4 | 9.5 | 2.7 | 0.6 | +12.1% |
| 2018 | -6.2 | -5.3 | -0.8 | -6.7 | 11.4 | -0.3 | 3.6 | 4.9 | 0.2 | -7.7 | -5.7 | -5.3 | −17.9% |
| 2017 | 10.2 | 0.6 | 2.4 | 6.7 | 1.6 | -5.0 | 1.9 | 9.5 | 1.7 | 9.2 | -4.1 | 4.8 | +45.6% |
| 2016 | -13.5 | 3.1 | -0.2 | 5.8 | 2.1 | 0.5 | 2.2 | -11.4 | 0.8 | -13.7 | -5.5 | 2.4 | −26.3% |
| 2015 | 15.8 | 7.5 | -1.7 | -3.2 | 6.1 | -2.6 | 11.5 | -18.3 | 0.4 | 8.1 | 7.9 | -2.6 | +27.3% |
| 2014 | 4.3 | 5.3 | -5.2 | 8.1 | 3.8 | 2.1 | 1.1 | -4.6 | -2.8 | 7.7 | -4.6 | -1.2 | +13.5% |
| 2013 | 13.3 | 10.4 | -1.0 | -0.9 | 1.7 | -7.8 | 4.7 | 7.1 | 2.5 | 2.0 | -1.3 | 7.8 | +43.8% |
| 2012 | -9.8 | 3.8 | -2.1 | -9.3 | 9.3 | -5.8 | -1.6 | 10.0 | -2.7 | -0.6 | -0.6 | 0.8 | −10.2% |
| 2011 | -3.0 | 0.3 | 6.6 | 8.0 | -0.1 | -3.7 | 1.2 | -10.3 | 4.6 | 1.4 | 10.1 | 0.0 | +14.1% |
| 2010 | 2.6 | 1.3 | 8.7 | 10.7 | -3.9 | 0.7 | 11.8 | -5.5 | 0.8 | 2.7 | 5.0 | 3.7 | +43.9% |
| 2009 | 11.6 | -6.3 | -7.3 | -5.3 | 8.7 | 3.4 | 8.9 | -5.1 | 7.5 | -2.8 | 7.0 | 8.4 | +29.2% |
| 2008 | -33.7 | 12.2 | 2.3 | -1.1 | 17.2 | -16.4 | 6.1 | 12.6 | -9.0 | -11.4 | -0.4 | 1.8 | −28.1% |
| 2007 | 1.6 | -1.6 | 2.7 | 15.4 | 3.1 | 7.7 | 1.3 | -0.2 | 1.5 | -14.8 | 0.0 | 3.7 | +19.5% |
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women's, children's cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.
Buy / hold / sell counts
No recent headlines.